Introduction

Mark structures strategic alliances, collaborations; joint ventures; licenses; and research, development, manufacturing, and distribution relationships to further clients' business objectives.

Mark R. Wicker advises clients on all aspects of acquiring, developing, commercializing, and licensing new technologies and products. His clients range from startups to well-established firms in the life sciences, technology, wireless, social media, clean tech, chemical, and material sciences industries. 

Mark has built a reputation for developing business models and business-focused legal solutions for the complex challenges biotechnology and life sciences companies face in bringing therapeutics and diagnostics to market. He also works closely with colleagues in IP and patent litigation to develop adversarial licensing programs and negotiate settlement and key licensing agreements. In addition, he has experience advising clients on venture capital financing, public securities offerings, and M&As. 

Mark regularly speaks and comments on life sciences and technology issues, including startup formation, capital raising, and licensing transactions.

Education & credentials

  • Columbia Law School, J.D., Head Writing and Research Editor, Columbia Journal of Transnational Law, 1985
  • Stanford University, A.B., with Distinction, 1982

Professional recognition

  • Named a “Top Artificial Intelligence Lawyer” by the Daily Journal, 2019

  • Recognized in The Best Lawyers in America: Biotechnology and Life Sciences Practice; Patent Law, 2008-2026; Technology Law, 2023-2026

  • Named Best Lawyers’ San Diego Patent Law "Lawyer of the Year," 2014

  • Recognized as a "Life Sciences Star" by LMG Life Sciences, 2014

  • Named one of the leading intellectual property and biotechnology lawyers in Southern California’s Best Lawyers, 2008-2009

  • Ranked by Chambers USA as “America’s Leading Lawyer" in California for Life Sciences: Corporate/Commercial, 2026